• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷脱氨酶及γ-干扰素释放试验在40岁以上患者胸腔积液中诊断结核性胸膜炎的应用

Application of Adenosine Deaminase and γ-Interferon Release Assay in Pleural Fluid for the Diagnosis of Tuberculous Pleural Effusion in Patients Over 40 Years Old.

作者信息

Li Zhishu, Chen Jiayue, Zeng Jia, Shi Ping, Xiong Xiaomin, Wang Meng, Zheng Dong, Zhao Rui, Dong Lixia

机构信息

Department of Respiratory and Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, People's Republic of China.

Department of Respiratory and Critical Care Medicine, Guangyuan Central Hospital, Guangyuan, People's Republic of China.

出版信息

Infect Drug Resist. 2023 Feb 17;16:1009-1018. doi: 10.2147/IDR.S400838. eCollection 2023.

DOI:10.2147/IDR.S400838
PMID:36824067
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9942497/
Abstract

BACKGROUND

In patients with tuberculous pleural effusion (TPE) of various ages, the diagnostic accuracy of pleural biomarkers varies, and there are insufficient studies specifically in different age groups. Therefore, we investigated the adenosine deaminase cut-off value and its combination with the gamma interferon release assay for the diagnosis of TPE among patients aged ≥40 years.

METHODS

A retrospective analysis of 198 patients who underwent medical thoracoscopy and were admitted to the hospital between 2015 and 2020 with exudative pleural effusion and either fever, night sweats, fatigue, cough, or other clinical manifestations was performed. The medical thoracoscopy, ADA, and T-SPOT results were analysed in the pleural fluid. The patients were divided into groups based on age: 18-39, 40-59, and 60-87.

RESULTS

The best cut-off values of ADA were 29.5, 31.5 and 19.5 U/L, respectively, for the aged 18-39, aged 40-87 and aged 60-87 groups. The accuracy of 31.5 U/L was higher than 40 U/L for aged ≥40 years (86 vs 83%). The ADA diagnostic accuracy was higher than that of people under 40 years (83 vs 77%) when cut-off value of ADA was 40 U/L, but the IGRA accuracy was lower than that of people under 40 (87 vs 91%). The sensitivity of ADA or IGRA detection in patients over 40 years was 99%, and the specificity was 78%. The ADA specificity combined with IGRA for TPE was the highest (100%) in the ≥40 age group, and the sensitivity was 69%.

CONCLUSION

Our study revealed the best cut-off values of ADA for TBE in different age groups. Combining ADA and IGRA in pleural fluid improves the detection rate of TPE in patients over 40 years of age with exudative pleural effusion. ADA combined with IGRA increases specificity, and ADA or IGRA increases sensitivity substantially.

摘要

背景

在不同年龄段的结核性胸腔积液(TPE)患者中,胸膜生物标志物的诊断准确性各不相同,且针对不同年龄组的专门研究不足。因此,我们研究了腺苷脱氨酶(ADA)的临界值及其与γ干扰素释放试验联合用于诊断年龄≥40岁患者的TPE情况。

方法

对198例接受内科胸腔镜检查且在2015年至2020年间因渗出性胸腔积液伴发热、盗汗、乏力、咳嗽或其他临床表现入院的患者进行回顾性分析。对胸腔积液中的内科胸腔镜检查、ADA和T-SPOT结果进行分析。患者按年龄分为三组:18 - 39岁、40 - 59岁和60 - 87岁。

结果

ADA的最佳临界值在18 - 39岁组、40 - 87岁组和60 - 87岁组分别为29.5、31.5和19.5 U/L。对于年龄≥40岁的患者,31.5 U/L的准确性高于40 U/L(分别为86%和83%)。当ADA临界值为40 U/L时,ADA的诊断准确性高于40岁以下人群(分别为83%和77%),但γ干扰素释放试验(IGRA)的准确性低于40岁以下人群(分别为87%和91%)。40岁以上患者中ADA或IGRA检测的敏感性为99%,特异性为78%。在≥40岁年龄组中,ADA特异性与IGRA联合用于TPE诊断时最高(100%),敏感性为69%。

结论

我们的研究揭示了不同年龄组TBE中ADA的最佳临界值。胸腔积液中ADA与IGRA联合可提高40岁以上渗出性胸腔积液患者TPE的检出率。ADA与IGRA联合可提高特异性,ADA或IGRA可显著提高敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9942497/932771ff2d15/IDR-16-1009-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9942497/81ad0844ee40/IDR-16-1009-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9942497/96104218ad63/IDR-16-1009-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9942497/932771ff2d15/IDR-16-1009-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9942497/81ad0844ee40/IDR-16-1009-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9942497/96104218ad63/IDR-16-1009-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b55/9942497/932771ff2d15/IDR-16-1009-g0003.jpg

相似文献

1
Application of Adenosine Deaminase and γ-Interferon Release Assay in Pleural Fluid for the Diagnosis of Tuberculous Pleural Effusion in Patients Over 40 Years Old.腺苷脱氨酶及γ-干扰素释放试验在40岁以上患者胸腔积液中诊断结核性胸膜炎的应用
Infect Drug Resist. 2023 Feb 17;16:1009-1018. doi: 10.2147/IDR.S400838. eCollection 2023.
2
Use of T-SPOT.TB for the diagnosis of unconventional pleural tuberculosis is superior to ADA in high prevalence areas: a prospective analysis of 601 cases.T-SPOT.TB 在高发地区用于诊断非典型性胸腔结核优于 ADA:一项 601 例前瞻性分析。
BMC Infect Dis. 2021 Jan 4;21(1):4. doi: 10.1186/s12879-020-05676-2.
3
Combined detections of interleukin 27, interferon-γ, and adenosine deaminase in pleural effusion for diagnosis of tuberculous pleurisy.胸腔积液中白细胞介素 27、干扰素-γ 和腺苷脱氨酶联合检测对结核性胸膜炎的诊断价值。
Chin Med J (Engl). 2013;126(17):3215-21.
4
Pleural fluid adenosine deaminase and interferon gamma as diagnostic tools in tuberculosis pleurisy.胸腔积液腺苷脱氨酶和干扰素γ作为结核性胸膜炎的诊断工具。
J Physiol Pharmacol. 2008 Dec;59 Suppl 6:349-60.
5
Influence of age on the diagnostic accuracy of soluble biomarkers for tuberculous pleural effusion: a post hoc analysis.年龄对结核性胸腔积液可溶性生物标志物诊断准确性的影响:一项事后分析。
BMC Pulm Med. 2020 Jun 22;20(1):178. doi: 10.1186/s12890-020-01219-2.
6
The pleural fluid lactate dehydrogenase/adenosine deaminase ratio differentiates between tuberculous and parapneumonic pleural effusions.胸腔积液乳酸脱氢酶/腺苷脱氨酶比值可区分结核性和类肺炎性胸腔积液。
BMC Pulm Med. 2017 Dec 4;17(1):168. doi: 10.1186/s12890-017-0526-z.
7
Clinical diagnostic utility of adenosine deaminase, interferon-γ, interferon-γ-induced protein of 10 kDa, and dipeptidyl peptidase 4 levels in tuberculous pleural effusions.腺苷脱氨酶、γ-干扰素、γ-干扰素诱导蛋白 10kDa 和二肽基肽酶 4 水平在结核性胸腔积液中的临床诊断价值。
Heart Lung. 2012 Jan-Feb;41(1):70-5. doi: 10.1016/j.hrtlng.2011.04.049. Epub 2011 Sep 13.
8
Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.胸腔干扰素-γ释放试验联合生物标志物可有效鉴别结核性胸腔积液和恶性胸腔积液。
BMC Infect Dis. 2019 Jan 16;19(1):55. doi: 10.1186/s12879-018-3654-z.
9
Pleural fluid adenosine deaminase/serum C-reactive protein ratio for the differentiation of tuberculous and parapneumonic effusions with neutrophilic predominance and high adenosine deaminase levels.用于鉴别以中性粒细胞为主且腺苷脱氨酶水平高的结核性和类肺炎性胸腔积液的胸腔积液腺苷脱氨酶/血清C反应蛋白比值
Infection. 2017 Feb;45(1):59-65. doi: 10.1007/s15010-016-0928-5. Epub 2016 Aug 3.
10
Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion.胸腔积液腺苷脱氨酶与血清 C 反应蛋白比值对结核性胸腔积液的诊断价值。
BMC Pulm Med. 2023 Sep 15;23(1):349. doi: 10.1186/s12890-023-02644-9.

引用本文的文献

1
Tired of the confusion around pleural effusions: Adenosine deaminase detection sets the record straight!厌倦了围绕胸腔积液的种种困惑:腺苷脱氨酶检测澄清事实!
World J Clin Cases. 2025 Jul 26;13(21):106945. doi: 10.12998/wjcc.v13.i21.106945.
2
A Storm of Polyserositis: Unravelling Multisystem Effusions in Hypereosinophilic Syndrome.多浆膜炎风暴:解析嗜酸性粒细胞增多综合征中的多系统积液
Cureus. 2024 Nov 21;16(11):e74170. doi: 10.7759/cureus.74170. eCollection 2024 Nov.
3
Diagnostic value of effusion adenosine deaminase, γ-interferon release assay and effusion lactatedehy drogenase/effusion adenosine deaminase for tuberculous pleural effusion in patients aged 60 years and above.

本文引用的文献

1
Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae.由于发病的结核病导致的终生疾病负担:包括结核后后遗症在内的全球再评估。
Lancet Glob Health. 2021 Dec;9(12):e1679-e1687. doi: 10.1016/S2214-109X(21)00367-3.
2
The negative impact of increasing age and underlying cirrhosis on the sensitivity of adenosine deaminase in the diagnosis of tuberculous peritonitis: a cross-sectional study in eastern China.年龄增长和潜在肝硬化对腺苷脱氨酶诊断结核性腹膜炎敏感性的负面影响:中国东部的一项横断面研究。
Int J Infect Dis. 2021 Sep;110:204-212. doi: 10.1016/j.ijid.2021.07.061. Epub 2021 Jul 29.
3
60 岁及以上老年结核性胸腔积液患者胸腔积液腺苷脱氨酶、γ-干扰素释放试验及乳酸脱氢酶/腺苷脱氨酶对诊断的价值。
Front Cell Infect Microbiol. 2024 Oct 9;14:1444238. doi: 10.3389/fcimb.2024.1444238. eCollection 2024.
The value of single or combined use of pleural fluid interferon gamma release assay in the diagnosis of tuberculous pleurisy.
胸腔积液干扰素释放试验单独或联合应用对结核性胸膜炎的诊断价值。
Trop Med Int Health. 2021 Nov;26(11):1356-1366. doi: 10.1111/tmi.13659. Epub 2021 Aug 1.
4
Use of T-SPOT.TB for the diagnosis of unconventional pleural tuberculosis is superior to ADA in high prevalence areas: a prospective analysis of 601 cases.T-SPOT.TB 在高发地区用于诊断非典型性胸腔结核优于 ADA:一项 601 例前瞻性分析。
BMC Infect Dis. 2021 Jan 4;21(1):4. doi: 10.1186/s12879-020-05676-2.
5
The Utility of Pleural Fluid Lactate Dehydrogenase to Adenosine Deaminase Ratio in Pleural Tuberculosis.胸腔积液乳酸脱氢酶/腺苷脱氨酶比值在结核性胸膜炎中的应用。
Respiration. 2021;100(1):59-63. doi: 10.1159/000509555. Epub 2020 Dec 17.
6
Adenosine deaminase cutoff value when diagnosing tuberculous pleurisy in patients aged 40 years and older.40 岁及以上患者诊断结核性胸膜炎时腺苷脱氨酶的截断值。
Clin Respir J. 2021 Jan;15(1):109-115. doi: 10.1111/crj.13277. Epub 2020 Oct 6.
7
Influence of age on the diagnostic accuracy of soluble biomarkers for tuberculous pleural effusion: a post hoc analysis.年龄对结核性胸腔积液可溶性生物标志物诊断准确性的影响:一项事后分析。
BMC Pulm Med. 2020 Jun 22;20(1):178. doi: 10.1186/s12890-020-01219-2.
8
The diagnostic utility of pleural markers for tuberculosis pleural effusion.胸膜标志物对结核性胸腔积液的诊断价值。
Ann Transl Med. 2020 May;8(9):607. doi: 10.21037/atm.2019.09.110.
9
Pleural fluid ADA activity in tuberculous pleurisy can be low in elderly, critically ill patients with multi-organ failure.结核性胸膜炎患者若为老年、危重症合并多器官功能衰竭,其胸液 ADA 活性可较低。
BMC Pulm Med. 2020 Jan 14;20(1):13. doi: 10.1186/s12890-020-1049-6.
10
Diagnostic Value of Pleural Effusion Mononuclear Cells Count and Adenosine Deaminase for Tuberculous Pleurisy Patients in China: A Case-Control Study.中国结核性胸膜炎患者胸腔积液单个核细胞计数及腺苷脱氨酶的诊断价值:一项病例对照研究
Front Med (Lausanne). 2019 Dec 17;6:301. doi: 10.3389/fmed.2019.00301. eCollection 2019.